Most importantly, introducing the fat-1 gene into the diabetes context resulted in abrogating CRC development and cell proliferation, while suppressing the expression of HNF-4α, β-catenin and β-catenin/Tcf-responsive genes, and promoting epithelial differentiation. This evidence concerns the gene FAT1 and colorectal carcinoma.